Home
Medical Courses
Webinars
Self-development
My Activity
Upfront Combination Therapy Ezetimibe & Statin: From Pathophysiology to Management Guidelines

Upfront Combination Therapy Ezetimibe & Statin: From Pathophysiology to Management Guidelines

CardiologyGeneral PracticeInternal MedicineFamily Medicine
A badge with ribbon in color black No CME/CPD credits | An analog clock in color black 45 minutes | A black calendar with white triangle in center that has a black exclamation point in the middle 05 Jun 2027 

Overview

About this course

This learning module will provide an overview of the treatment gaps in LDL-control, the importance of early and sustained LDL-C reduction and the evidence supporting upfront statin-ezetimibe combination therapy in high and very high-risk patients.

Learning outcomes

  • Understand current treatment gaps in lipid management
  • Understand the benefits of early and sustained LDL-C lowering
  • Apply to clinical practice the appropriate use of statin-ezetimibe therapy

Topics covered:

Dyslipidemia, ASCVD, Ezetimibe, Lipid lowering therapy, statins

Speaker

Lourdes Ella G. Santos, MD.jpg

Lourdes Ella G. Santos, MD

Head, Preventive Cardiology, Cardiovascular Institute, Cardinal Santos

Medical Center

Director II, Philippine Heart Association

Something went wrong.